Alicia F. Brantley, PhD
Scientific Director
Mouse Behavior Core
Scripps Research
Increasing Reproducibility and
Reliability of Novel Object
Tests Through Standardization
and Automation
An expert shares her work involving novel
object tests, the challenges associated with
these protocols, and the solutions she is
exploring to overcome these challenges.
Increasing Reproducibility and
Reliability of Novel Object
Tests Through Standardization
and Automation
Copyright 2021 A. Brantley and InsideScientific. All Rights Reserved.
Alicia F. Brantley, PhD
Scientific Director
Mouse Behavior Core
Scripps Research
Increasing Reproducibility and
Reliability of Novel Object
Tests Through Standardization
and Automation
Novel Object Tests
• First developed by Ennaceur and Delacour in rats as a “pure
working memory test” with a 1-min retention interval
• Basic protocol: rodents explore 2 alike objects after habituation to
arena; after a delay (varies from short- to long-term, 1-24 hrs
usually), one object is replaced with a novel object (Novel Object
Recognition) or one object is moved to a novel location within the
arena (Novel Object Location)
• Analysis varies, usually by protocol; discrimination ratio vs.
comparison to chance
Replicating Novel Object Tests
• Protocols vary greatly
• Published methodological details are vague
• Objects can be anything, difficult to duplicate
• Observer-based scoring parameters vary
• Analysis choice affects result
Added Complication – Core Assay
How to take a task that is so lab-specific and make it work for
multiple labs with varied research experience and still be a valid,
replicable assay?
Some degree of standardization is necessary.
Automated scoring of exploration is preferable.
Object Placement
• Floor insert for open
field with a circular
cutout in each corner
• Blank disks fill in holes
when not needed to
make solid floor
• LED surround light bar
for even lighting of
objects and shadow
reduction
Object Choice
• First iteration – found lab
items epoxied to blank
disks
• Exploration was not
great
• Mice would climb on
them often,
complicating
automation of
exploration detection
Object Choice
What can mice see?
What is an “interesting” object and
what is a “scary” object?
How different do two “different”
objects need to be?
How tall should the objects be?
Will the objects affect automated
tracking?
• 3D printed objects
• Can create whatever I
want and replicate at
any time
• Objects can be like
common objects but
without seams or
difficulty replacing
• How to determine an
object to design?
Object Choice
• First 3D printed items
• Climbable
• One was highly
preferred over the
other
• Easy to revise designs
and print new options
Object Choice
• Current 3D printed items
• Approachable
• Difficult to climb/stand
on
• Differ in
texture/temperature
due to addition of
metal coil on one
object
Automating Object Exploration
First: which protocol?
• Fixed duration protocols – training and testing phases each given a fixed
amount of time (usually 10 minutes) during which the animal can freely
explore the object
• Exploration-based cutoff protocols – training only or training and testing
phases allowed to continue until a predetermined cumulative exploration time
is met (usually ~30 seconds)
• Controls for individual differences in exploration
Tuscher JJ, Fortress AM, Kim J, Frick KM. Regulation of object recognition and object placement by ovarian sex steroid hormones.
Behav Brain Res. 2015 May 15;285:140-57. doi: 10.1016/j.bbr.2014.08.001. Epub 2014 Aug 15. PMID: 25131507; PMCID:
PMC4329280.
Automating Object Exploration
How do we define exploration?
Ennaceur and Delacour (1988) defined exploration as “the directing the nose at a
distance 2 cm to the object and/or touching it with the nose,” while turning around or
sitting on the object was not considered exploration.
• Orientation of animal’s snout toward the object, sniffing or touching with snout
• Sometimes defined as the animal’s head oriented within 45 degrees of the object
• Primary difference between studies was the distance from the snout to the object;
varies usually within 1–4 cm distance from the object
Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012
May;13(2):93-110. doi: 10.1007/s10339-011-0430-z. Epub 2011 Dec 9. PMID: 22160349; PMCID: PMC3332351.
Automating Object Exploration
How do we define exploration using EthoVision XT?
• Accurately assign nose point – cannot designate active interest in an object
unless the mouse’s face is at the very least in proximity to the object.
• Determine proximity distance threshold
• Identify orientation towards object
Improving Detection – Deep Learning
Deep learning refers to the use of deep neural networks, where “deep” indicates that
the networks are made of multiple, hidden layers of “neurons” or decision nodes.
Deep learning in EthoVision XT
• A deep neural network can find structures in unstructured data, like for pictures and
video images, and can recognize recurring patterns and relationships between those
patterns.
• Because of the layered structure of decision nodes, deep neural networks can learn to
represent data at various levels.
• EthoVision XT uses a trained network, that is, the network has learned to extract
features from a number of video images of rodents of various colors and in various
backgrounds, where the nose and the tail-base were previously annotated. During
tracking, the network analyzes a portion of the image that includes the detected
subject and makes an estimate of the position of the nose point and the tail-base
point.
Initial Cutoff Criteria
• Based on tracking of nose
point inside small area
around objects
• Set cutoff time to 45
seconds, longer than end
goal of 30 seconds
Refining Variables
• Choosing most accurate
variable
• Defining appropriate search
areas for higher accuracy
• Determination of
exploration is now easily
replicable
Refining Variables
• Choosing most accurate
variable
• Defining appropriate search
areas for higher accuracy
• Determination of
exploration is now easily
replicable
Redefine Cutoff
Criteria
• Apply refined
detection of
exploration to Trial
Control Settings
• Can now accurately
automate
exploration in real
time for future
experiments
Redefine Cutoff
Criteria
• Apply refined
detection of
exploration to Trial
Control Settings
• Can now accurately
automate
exploration in real
time for future
experiments
Redefine Cutoff
Criteria
• Apply refined
detection of
exploration to Trial
Control Settings
• Can now accurately
automate
exploration in real
time for future
experiments
Providing Replicable Methodological Details
All equipment and software details are easily shared
• Object 3D print file can be saved to cloud and shared in methodology.
• Open field and floor insert dimensions can be provided in equipment
description.
• Precise arena zone dimensions can be listed.
• “Exploration” condition definitions (from Trial Control Settings) can be
provided.
• Actual EthoVision XT template can be shared from cloud source.
Data Analysis – Which Method?
All equipment and software details are easily shared
• Discrimination ratios:
(Tnovel− Tfamiliar)/(Tnovel+ Tfamiliar) or Tnovel/(Tnovel+ Tfamiliar)
values near zero indicate chance performance, values greater than or
equal to 0.5, or greater than 0.5 (respectively) indicate preference
• One-sample t-test compared to chance performance
if total allowed exploration time = 30s, chance = 15s
Raw data
• Compare novel exploration
time (out of 30s) to chance
(15s) using one sample t-test
• Same data converted to a
discrimination ratio using
familiar object exploration time
Group
Time Novel Object
Exploration (s)
Tnovel/
(Tnovel+Tfamiliar)
(Tnovel− Tfamiliar)/
(Tnovel+Tfamiliar)
old 147.88 -0.15 4.92
17 12.24 -0.19 0.41
18 18.16 0.21 0.60
19 22.48 0.50 0.75
20 19.44 0.29 0.65
23 4.80 -0.68 0.16
25 13.60 -0.09 0.45
26 7.68 -0.49 0.26
27 19.32 0.29 0.64
28 16.64 0.11 0.55
30 13.52 -0.10 0.45
young 207.84 1.84 6.92
1 9.60 -0.36 0.32
10 9.96 -0.34 0.33
11 20.52 0.37 0.68
12 17.84 0.19 0.59
13 16.80 0.12 0.56
14 22.64 0.51 0.75
2 17.56 0.17 0.58
3 22.48 0.50 0.75
4 21.04 0.40 0.70
7 23.96 0.60 0.80
8 11.96 -0.20 0.40
9 13.48 -0.10 0.45
old-c 60.08 0.00 2.00
31 12.72 -0.15 0.42
32 21.04 0.40 0.70
132 9.00 -0.40 0.30
131 17.32 0.15 0.58
young-c 120.16 0.00 4.00
15 22.00 0.46 0.73
16 19.56 0.30 0.65
5 5.60 -0.63 0.19
6 5.56 -0.63 0.19
105 24.44 0.63 0.81
116 10.48 -0.30 0.35
106 24.48 0.63 0.81
115 8.04 -0.46 0.27
Grand Total 535.96 1.68 17.84
NOR Outcomes
Young mice Old mice
0
5
10
15
20
25
30
time
exploring
novel
object
(s)
NOR Outcomes
Y
o
u
n
g
m
i
c
e
O
l
d
m
i
c
e
y
o
u
n
g
c
o
n
t
r
o
l
o
l
d
c
o
n
t
r
o
l
0
5
10
15
20
25
30
time
exploring
novel
object
(s)
y
o
u
n
g
r
a
t
i
o
o
l
d
r
a
t
i
o
y
o
u
n
g
c
o
n
t
r
o
l
r
a
t
i
o
o
l
d
c
o
n
t
r
o
l
r
a
t
i
o
0.0
0.2
0.4
0.6
0.8
1.0
discrimination
ratio
y
o
u
n
g
r
a
t
i
o
c
s
v
o
l
d
r
a
t
i
o
c
s
v
y
o
u
n
g
c
o
n
t
r
o
l
r
a
t
i
o
c
s
v
o
l
d
c
o
n
t
r
o
l
r
a
t
i
o
c
s
v
-1.0
-0.5
0.0
0.5
1.0
discrimintion
ratio
Replicating Novel Object Tests
• Utilize available technology
• Reporting methods with detail
• Rely on automated tracking (always validate)
• Share with other labs/institutions
Thank you!
Ruud Tegelenbosch, MSc
Matt Feltenstein PhD
Alicia F. Brantley, PhD
Scientific Director
Mouse Behavior Core
Scripps Research
Thank you for participating!
CLICK HERE to learn more and
watch the webinar
Thank you for participating!
Before you go…
1. Complete the Survey – we’d love to get your
feedback
2. Still have questions? Use the Ask a Question
panel
3. Interested in learning more? Explore the
Resources or visit www.noldus.com

More Related Content

PPTX
PPT on Vigiflow, Argus-G and Aris For ADR Reporting
PPTX
INVESTIGATIONAL NEW DRUG (IND)
PPTX
Recent advances in the management of alzheimers disease
PDF
Toxicology in Drug Development
PPTX
Investigator Role and Responsibilities
PPT
Good Clinical Practice Guidelines (ICH GCP E6).ppt
PPTX
Recent advances in the treatment of alzheimer's disease
PPTX
Pharmacotherapy of asthma and copd 1.pptx
PPT on Vigiflow, Argus-G and Aris For ADR Reporting
INVESTIGATIONAL NEW DRUG (IND)
Recent advances in the management of alzheimers disease
Toxicology in Drug Development
Investigator Role and Responsibilities
Good Clinical Practice Guidelines (ICH GCP E6).ppt
Recent advances in the treatment of alzheimer's disease
Pharmacotherapy of asthma and copd 1.pptx

What's hot (20)

PPTX
Conflict of interest_Dr. Mansij Biswas
PPTX
introduction to Pharmacoepidemiology
PPTX
Preclinical screening of new substance for pharmacological activity
PPTX
Aris G PHARMACOVIGILANCE AND VIGIFLOW
PPTX
RECENT ADVANCES IN ALZHEIMER'S DISEASE
PPTX
Oecd guide line2
PPTX
Clinical trial study team
PPTX
Screening of anti alzheimers
PPTX
Drug discovery
PPTX
Pre clinical screening of anti epileptic drugs
PPT
Animal models of diabetes
PPT
Clinical research coordinator responsibilities
PPTX
industrial prespectives of IND
PPTX
Recent Advances in the treatment of Parkinson's Disease.pptx
PPTX
Role of Target Identification and Target Validation in Drug Discovery Process
PDF
Evaluating clinical studies - Drug information
PPTX
Pharmacovigilance in real life may 12
PPTX
Declaration of helsinki
PPTX
Principles of drug discovery.pptx
PPTX
Pharmacoepidemiology
Conflict of interest_Dr. Mansij Biswas
introduction to Pharmacoepidemiology
Preclinical screening of new substance for pharmacological activity
Aris G PHARMACOVIGILANCE AND VIGIFLOW
RECENT ADVANCES IN ALZHEIMER'S DISEASE
Oecd guide line2
Clinical trial study team
Screening of anti alzheimers
Drug discovery
Pre clinical screening of anti epileptic drugs
Animal models of diabetes
Clinical research coordinator responsibilities
industrial prespectives of IND
Recent Advances in the treatment of Parkinson's Disease.pptx
Role of Target Identification and Target Validation in Drug Discovery Process
Evaluating clinical studies - Drug information
Pharmacovigilance in real life may 12
Declaration of helsinki
Principles of drug discovery.pptx
Pharmacoepidemiology
Ad

Similar to Increasing Reproducibility and Reliability of Novel Object Tests Through Standardization and Automation (20)

PPTX
Innovative Approaches to Tracking and Quantifying Behavior in Rodents
PDF
Multimodal behavior signal analysis and interpretation for young kids with ASD
PPTX
DeepLabCut AI Residency
PPTX
Behavioral phenotyping of mouse models of neurodegeneration
PPTX
Towards automated phenotypic cell profiling with high-content imaging
PDF
Cancer Practitioner Personal Statement
PDF
Inglis PhD Thesis
PDF
MH_Report
PDF
Neural Network based Supervised Self Organizing Maps for Face Recognition
PDF
NEURAL NETWORK BASED SUPERVISED SELF ORGANIZING MAPS FOR FACE RECOGNITION
PPT
siftppthttps://www.youtube.com/watch?v=ckftH9saonM.ppt
PDF
Zen and the Art of Data Science Maintenance
PDF
Age Invariant Face Recognition
PPS
Stefan Klein
PPTX
PPT_ Module_2_suruchi presentation notes
PPTX
How to investigate behavior and cognitive abilities in rodents in a social gr...
PDF
Laura Furlong. Big Data in Biomedicine debate. Barcelona, Nov 11 2014
PDF
Diagnostic hypothesis refinement in reproducible workflows for advanced medic...
PPTX
2016 bergen-sars
PPTX
Wayfinding objects mechanism
Innovative Approaches to Tracking and Quantifying Behavior in Rodents
Multimodal behavior signal analysis and interpretation for young kids with ASD
DeepLabCut AI Residency
Behavioral phenotyping of mouse models of neurodegeneration
Towards automated phenotypic cell profiling with high-content imaging
Cancer Practitioner Personal Statement
Inglis PhD Thesis
MH_Report
Neural Network based Supervised Self Organizing Maps for Face Recognition
NEURAL NETWORK BASED SUPERVISED SELF ORGANIZING MAPS FOR FACE RECOGNITION
siftppthttps://www.youtube.com/watch?v=ckftH9saonM.ppt
Zen and the Art of Data Science Maintenance
Age Invariant Face Recognition
Stefan Klein
PPT_ Module_2_suruchi presentation notes
How to investigate behavior and cognitive abilities in rodents in a social gr...
Laura Furlong. Big Data in Biomedicine debate. Barcelona, Nov 11 2014
Diagnostic hypothesis refinement in reproducible workflows for advanced medic...
2016 bergen-sars
Wayfinding objects mechanism
Ad

More from InsideScientific (20)

PDF
Next-Generation Safety Assessment Tools for Advancing In Vivo to In Vitro Tra...
PDF
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cance...
PDF
Molecule Transport across Cell Membranes: Electrochemical Quantification at t...
PDF
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in ...
PDF
Exploring Estrogen’s Role in Metabolism and the Use of 13C-Labeled Nutrients ...
PDF
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
PDF
Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line an...
PDF
How to Create CRISPR-Edited T Cells More Efficiently for Tomorrow's Cell Ther...
PDF
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
PDF
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
PDF
Simple Tips to Significantly Improve Rodent Surgical Outcomes
PPTX
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
PDF
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
PDF
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
PDF
Designing Causal Inference Studies Using Real-World Data
PDF
Social Media Data: Opportunities and Insights for Clinical Research
PPTX
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
PDF
Antibody Discovery by Single B Cell Screening on Beacon®
PPTX
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
PDF
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...
Next-Generation Safety Assessment Tools for Advancing In Vivo to In Vitro Tra...
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cance...
Molecule Transport across Cell Membranes: Electrochemical Quantification at t...
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in ...
Exploring Estrogen’s Role in Metabolism and the Use of 13C-Labeled Nutrients ...
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
Fully Characterized, Standardized Human Induced Pluripotent Stem Cell Line an...
How to Create CRISPR-Edited T Cells More Efficiently for Tomorrow's Cell Ther...
Peripheral and Cerebral Vascular Responses Following High-Intensity Interval ...
Leveraging Programmable CRISPR-Associated Transposases for Next-Generation Ge...
Simple Tips to Significantly Improve Rodent Surgical Outcomes
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection a...
Creating Better Gene-Edited Cell Lines with the FAST-HDR System
Functional Recovery of the Musculoskeletal System Following Injury - Leveragi...
Designing Causal Inference Studies Using Real-World Data
Social Media Data: Opportunities and Insights for Clinical Research
We Are More Than What We Eat Dietary Interventions Depend on Sex and Genetic ...
Antibody Discovery by Single B Cell Screening on Beacon®
Experimental Design Considerations to Optimize Chronic Cardiovascular Telemet...
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...

Recently uploaded (20)

PDF
Is Earendel a Star Cluster?: Metal-poor Globular Cluster Progenitors at z ∼ 6
PPT
Biochemestry- PPT ON Protein,Nitrogenous constituents of Urine, Blood, their ...
PPTX
GREEN FIELDS SCHOOL PPT ON HOLIDAY HOMEWORK
PPTX
ELISA(Enzyme linked immunosorbent assay)
PDF
Integrative Oncology: Merging Conventional and Alternative Approaches (www.k...
PDF
Worlds Next Door: A Candidate Giant Planet Imaged in the Habitable Zone of ↵ ...
PPTX
Platelet disorders - thrombocytopenia.pptx
PPTX
limit test definition and all limit tests
PPTX
diabetes and its complications nephropathy neuropathy
PPT
THE CELL THEORY AND ITS FUNDAMENTALS AND USE
PDF
Packaging materials of fruits and vegetables
PPT
Enhancing Laboratory Quality Through ISO 15189 Compliance
PDF
Social preventive and pharmacy. Pdf
PPT
1. INTRODUCTION TO EPIDEMIOLOGY.pptx for community medicine
PPTX
bone as a tissue presentation micky.pptx
PPTX
PMR- PPT.pptx for students and doctors tt
PPTX
endocrine - management of adrenal incidentaloma.pptx
PDF
Worlds Next Door: A Candidate Giant Planet Imaged in the Habitable Zone of ↵ ...
PPT
Animal tissues, epithelial, muscle, connective, nervous tissue
PDF
Communicating Health Policies to Diverse Populations (www.kiu.ac.ug)
Is Earendel a Star Cluster?: Metal-poor Globular Cluster Progenitors at z ∼ 6
Biochemestry- PPT ON Protein,Nitrogenous constituents of Urine, Blood, their ...
GREEN FIELDS SCHOOL PPT ON HOLIDAY HOMEWORK
ELISA(Enzyme linked immunosorbent assay)
Integrative Oncology: Merging Conventional and Alternative Approaches (www.k...
Worlds Next Door: A Candidate Giant Planet Imaged in the Habitable Zone of ↵ ...
Platelet disorders - thrombocytopenia.pptx
limit test definition and all limit tests
diabetes and its complications nephropathy neuropathy
THE CELL THEORY AND ITS FUNDAMENTALS AND USE
Packaging materials of fruits and vegetables
Enhancing Laboratory Quality Through ISO 15189 Compliance
Social preventive and pharmacy. Pdf
1. INTRODUCTION TO EPIDEMIOLOGY.pptx for community medicine
bone as a tissue presentation micky.pptx
PMR- PPT.pptx for students and doctors tt
endocrine - management of adrenal incidentaloma.pptx
Worlds Next Door: A Candidate Giant Planet Imaged in the Habitable Zone of ↵ ...
Animal tissues, epithelial, muscle, connective, nervous tissue
Communicating Health Policies to Diverse Populations (www.kiu.ac.ug)

Increasing Reproducibility and Reliability of Novel Object Tests Through Standardization and Automation

  • 1. Alicia F. Brantley, PhD Scientific Director Mouse Behavior Core Scripps Research Increasing Reproducibility and Reliability of Novel Object Tests Through Standardization and Automation
  • 2. An expert shares her work involving novel object tests, the challenges associated with these protocols, and the solutions she is exploring to overcome these challenges. Increasing Reproducibility and Reliability of Novel Object Tests Through Standardization and Automation
  • 3. Copyright 2021 A. Brantley and InsideScientific. All Rights Reserved. Alicia F. Brantley, PhD Scientific Director Mouse Behavior Core Scripps Research Increasing Reproducibility and Reliability of Novel Object Tests Through Standardization and Automation
  • 4. Novel Object Tests • First developed by Ennaceur and Delacour in rats as a “pure working memory test” with a 1-min retention interval • Basic protocol: rodents explore 2 alike objects after habituation to arena; after a delay (varies from short- to long-term, 1-24 hrs usually), one object is replaced with a novel object (Novel Object Recognition) or one object is moved to a novel location within the arena (Novel Object Location) • Analysis varies, usually by protocol; discrimination ratio vs. comparison to chance
  • 5. Replicating Novel Object Tests • Protocols vary greatly • Published methodological details are vague • Objects can be anything, difficult to duplicate • Observer-based scoring parameters vary • Analysis choice affects result
  • 6. Added Complication – Core Assay How to take a task that is so lab-specific and make it work for multiple labs with varied research experience and still be a valid, replicable assay? Some degree of standardization is necessary. Automated scoring of exploration is preferable.
  • 7. Object Placement • Floor insert for open field with a circular cutout in each corner • Blank disks fill in holes when not needed to make solid floor • LED surround light bar for even lighting of objects and shadow reduction
  • 8. Object Choice • First iteration – found lab items epoxied to blank disks • Exploration was not great • Mice would climb on them often, complicating automation of exploration detection
  • 9. Object Choice What can mice see? What is an “interesting” object and what is a “scary” object? How different do two “different” objects need to be? How tall should the objects be? Will the objects affect automated tracking? • 3D printed objects • Can create whatever I want and replicate at any time • Objects can be like common objects but without seams or difficulty replacing • How to determine an object to design?
  • 10. Object Choice • First 3D printed items • Climbable • One was highly preferred over the other • Easy to revise designs and print new options
  • 11. Object Choice • Current 3D printed items • Approachable • Difficult to climb/stand on • Differ in texture/temperature due to addition of metal coil on one object
  • 12. Automating Object Exploration First: which protocol? • Fixed duration protocols – training and testing phases each given a fixed amount of time (usually 10 minutes) during which the animal can freely explore the object • Exploration-based cutoff protocols – training only or training and testing phases allowed to continue until a predetermined cumulative exploration time is met (usually ~30 seconds) • Controls for individual differences in exploration Tuscher JJ, Fortress AM, Kim J, Frick KM. Regulation of object recognition and object placement by ovarian sex steroid hormones. Behav Brain Res. 2015 May 15;285:140-57. doi: 10.1016/j.bbr.2014.08.001. Epub 2014 Aug 15. PMID: 25131507; PMCID: PMC4329280.
  • 13. Automating Object Exploration How do we define exploration? Ennaceur and Delacour (1988) defined exploration as “the directing the nose at a distance 2 cm to the object and/or touching it with the nose,” while turning around or sitting on the object was not considered exploration. • Orientation of animal’s snout toward the object, sniffing or touching with snout • Sometimes defined as the animal’s head oriented within 45 degrees of the object • Primary difference between studies was the distance from the snout to the object; varies usually within 1–4 cm distance from the object Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012 May;13(2):93-110. doi: 10.1007/s10339-011-0430-z. Epub 2011 Dec 9. PMID: 22160349; PMCID: PMC3332351.
  • 14. Automating Object Exploration How do we define exploration using EthoVision XT? • Accurately assign nose point – cannot designate active interest in an object unless the mouse’s face is at the very least in proximity to the object. • Determine proximity distance threshold • Identify orientation towards object
  • 15. Improving Detection – Deep Learning Deep learning refers to the use of deep neural networks, where “deep” indicates that the networks are made of multiple, hidden layers of “neurons” or decision nodes. Deep learning in EthoVision XT • A deep neural network can find structures in unstructured data, like for pictures and video images, and can recognize recurring patterns and relationships between those patterns. • Because of the layered structure of decision nodes, deep neural networks can learn to represent data at various levels. • EthoVision XT uses a trained network, that is, the network has learned to extract features from a number of video images of rodents of various colors and in various backgrounds, where the nose and the tail-base were previously annotated. During tracking, the network analyzes a portion of the image that includes the detected subject and makes an estimate of the position of the nose point and the tail-base point.
  • 16. Initial Cutoff Criteria • Based on tracking of nose point inside small area around objects • Set cutoff time to 45 seconds, longer than end goal of 30 seconds
  • 17. Refining Variables • Choosing most accurate variable • Defining appropriate search areas for higher accuracy • Determination of exploration is now easily replicable
  • 18. Refining Variables • Choosing most accurate variable • Defining appropriate search areas for higher accuracy • Determination of exploration is now easily replicable
  • 19. Redefine Cutoff Criteria • Apply refined detection of exploration to Trial Control Settings • Can now accurately automate exploration in real time for future experiments
  • 20. Redefine Cutoff Criteria • Apply refined detection of exploration to Trial Control Settings • Can now accurately automate exploration in real time for future experiments
  • 21. Redefine Cutoff Criteria • Apply refined detection of exploration to Trial Control Settings • Can now accurately automate exploration in real time for future experiments
  • 22. Providing Replicable Methodological Details All equipment and software details are easily shared • Object 3D print file can be saved to cloud and shared in methodology. • Open field and floor insert dimensions can be provided in equipment description. • Precise arena zone dimensions can be listed. • “Exploration” condition definitions (from Trial Control Settings) can be provided. • Actual EthoVision XT template can be shared from cloud source.
  • 23. Data Analysis – Which Method? All equipment and software details are easily shared • Discrimination ratios: (Tnovel− Tfamiliar)/(Tnovel+ Tfamiliar) or Tnovel/(Tnovel+ Tfamiliar) values near zero indicate chance performance, values greater than or equal to 0.5, or greater than 0.5 (respectively) indicate preference • One-sample t-test compared to chance performance if total allowed exploration time = 30s, chance = 15s
  • 24. Raw data • Compare novel exploration time (out of 30s) to chance (15s) using one sample t-test • Same data converted to a discrimination ratio using familiar object exploration time Group Time Novel Object Exploration (s) Tnovel/ (Tnovel+Tfamiliar) (Tnovel− Tfamiliar)/ (Tnovel+Tfamiliar) old 147.88 -0.15 4.92 17 12.24 -0.19 0.41 18 18.16 0.21 0.60 19 22.48 0.50 0.75 20 19.44 0.29 0.65 23 4.80 -0.68 0.16 25 13.60 -0.09 0.45 26 7.68 -0.49 0.26 27 19.32 0.29 0.64 28 16.64 0.11 0.55 30 13.52 -0.10 0.45 young 207.84 1.84 6.92 1 9.60 -0.36 0.32 10 9.96 -0.34 0.33 11 20.52 0.37 0.68 12 17.84 0.19 0.59 13 16.80 0.12 0.56 14 22.64 0.51 0.75 2 17.56 0.17 0.58 3 22.48 0.50 0.75 4 21.04 0.40 0.70 7 23.96 0.60 0.80 8 11.96 -0.20 0.40 9 13.48 -0.10 0.45 old-c 60.08 0.00 2.00 31 12.72 -0.15 0.42 32 21.04 0.40 0.70 132 9.00 -0.40 0.30 131 17.32 0.15 0.58 young-c 120.16 0.00 4.00 15 22.00 0.46 0.73 16 19.56 0.30 0.65 5 5.60 -0.63 0.19 6 5.56 -0.63 0.19 105 24.44 0.63 0.81 116 10.48 -0.30 0.35 106 24.48 0.63 0.81 115 8.04 -0.46 0.27 Grand Total 535.96 1.68 17.84
  • 25. NOR Outcomes Young mice Old mice 0 5 10 15 20 25 30 time exploring novel object (s)
  • 27. Replicating Novel Object Tests • Utilize available technology • Reporting methods with detail • Rely on automated tracking (always validate) • Share with other labs/institutions
  • 28. Thank you! Ruud Tegelenbosch, MSc Matt Feltenstein PhD
  • 29. Alicia F. Brantley, PhD Scientific Director Mouse Behavior Core Scripps Research Thank you for participating! CLICK HERE to learn more and watch the webinar
  • 30. Thank you for participating! Before you go… 1. Complete the Survey – we’d love to get your feedback 2. Still have questions? Use the Ask a Question panel 3. Interested in learning more? Explore the Resources or visit www.noldus.com